Medical Scientist Associate – Cell Therapy Brazil at Gilead Sciences

Sao Paulo, Sao Paulo, Brazil

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Highly motivated individual suitable for a field-based position reporting to the Brazil Medical Lead
Expertise in clinical, scientific, and technical knowledge of hematology/oncology and the company’s therapeutic areas of interest
Ability to engage in peer-to-peer scientific exchange of complex clinical and scientific information
Strong relationship-building skills with Thought Leaders (TLs), disease experts, and other health care providers (HCPs) in academic and community practices
Adherence to corporate and health care compliance guidance in all activities, including clinical trials and scientific interactions
Passion and ambition aligned with Gilead/Kite's mission in cell therapy and immunotherapy

Responsibilities

Engage in peer-to-peer scientific exchange of complex clinical and scientific information
Develop and foster strong scientific relationships with Thought Leaders (TLs), disease experts, and other health care providers (HCPs)
Provide clinical/scientific presentations to internal and external groups
Compliantly provide internal teams with feedback and insights from interactions and discussions with HCPs
Engage in accrual enhancement activities with clinical trial sites
Provide support at professional meetings, including staffing exhibits, reporting on scientific sessions, and facilitating meetings with TLs and HCPs
Adhere to corporate and health care compliance guidance in all activities, including those related to clinical trials, scientific interactions, and responses to unsolicited requests for medical/scientific information
Maintain clinical, scientific, and technical expertise in hematology/oncology and the company’s therapeutic areas of interest
Represent the company and Medical Affairs during exchanges with the medical and scientific community
Establish and maintain ongoing long-term collaborative relationships with HCPs (including physicians, nurses, and other allied health professionals) within assigned territory
Respond to and document unsolicited requests for scientific information
Provide clinical input and training to internal functions as requested
Provide support for content development and delivery of clinical presentations at Advisory Boards, as requested
Work closely with other field-based employees and headquarters-based teams

Skills

Cell Therapy

CAR T-cell Therapy

Immunotherapy

Hematology

Oncology

Thought Leader Engagement

Relationship Management

Medical Affairs

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free